Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies

Cancer is one of the leading causes of human death. In 2019, it was reported that cancer was the second (22%) cause of death due to non-communicable diseases in the world's population. Research for alternative anticancer drugs is still being done, including anticancer from plants. One of the p...

Full description

Bibliographic Details
Main Authors: Muhammad Fikriansyah, Nelson, Madyawati Latief, Indra Lasmana Tarigan
Format: Article
Language:Indonesian
Published: Universitas Jambi 2023-07-01
Series:Chempublish Journal
Subjects:
Online Access:http://online-journal.unja.ac.id/chp/article/view/23726
_version_ 1797767046731137024
author Muhammad Fikriansyah
Nelson
Madyawati Latief
Indra Lasmana Tarigan
author_facet Muhammad Fikriansyah
Nelson
Madyawati Latief
Indra Lasmana Tarigan
author_sort Muhammad Fikriansyah
collection DOAJ
description Cancer is one of the leading causes of human death. In 2019, it was reported that cancer was the second (22%) cause of death due to non-communicable diseases in the world's population. Research for alternative anticancer drugs is still being done, including anticancer from plants. One of the plants that have the potential to be developed as an anticancer alternative is the sungkai plant. Sungkai leaves contain many bioactive compounds, one of which is the clerodane-type diterpenoids, peronemins, A2 (1), A3 (2), B1 (3), B2 (4), B3 (5), C1 (6), and D1 (7). The aim of this study was to initial screen the potential of seven Peronemins compounds in Sungkai leaves extract as anticancer candidates. Initial screening was carried out by predicting in-silico anticancer activity of the seven compounds. Dihydrofolate reductase inhibitor (DHFR inhibitor) is one of the anticancer activity screening approaches. DHFR Inhibitor activity from perenomins derivatives with pIC50 values ​​of 0.785 (A2), respectively; 0.785 (A3); 0.799 (B2); 0.799 (B3); 0.799 (C1 and D1). In addition, from compounds 1,2,3,4,5 peronemin derivatives have potential anticancer activity through interaction with the target protein Voltage-gated potassium channel subunit while compounds 6, 7 also have biological activity potential anticancer on target protein Dihydrofolate reductase.
first_indexed 2024-03-12T20:33:30Z
format Article
id doaj.art-ab3799e0520d4a0093d2119f24716421
institution Directory Open Access Journal
issn 2503-4588
language Indonesian
last_indexed 2024-03-12T20:33:30Z
publishDate 2023-07-01
publisher Universitas Jambi
record_format Article
series Chempublish Journal
spelling doaj.art-ab3799e0520d4a0093d2119f247164212023-08-01T16:54:06ZindUniversitas JambiChempublish Journal2503-45882023-07-017110.22437/chp.v7i1.23726Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction StudiesMuhammad Fikriansyah0Nelson1Madyawati Latief2Indra Lasmana Tarigan3Department of Chemistry, Faculty of Science and Technology, Universitas Jambi, Muara Jambi 36361, JambiDepartment of Chemical Analyst, Faculty of Science and Technology, Universitas Jambi, Muara Jambi 36361, JambiDepartment of Chemistry, Faculty of Science and Technology, Universitas Jambi, Muara Jambi 36361, JambiDepartment of Chemistry, Faculty of Science and Technology, Universitas Jambi, Muara Jambi 36361, Jambi Cancer is one of the leading causes of human death. In 2019, it was reported that cancer was the second (22%) cause of death due to non-communicable diseases in the world's population. Research for alternative anticancer drugs is still being done, including anticancer from plants. One of the plants that have the potential to be developed as an anticancer alternative is the sungkai plant. Sungkai leaves contain many bioactive compounds, one of which is the clerodane-type diterpenoids, peronemins, A2 (1), A3 (2), B1 (3), B2 (4), B3 (5), C1 (6), and D1 (7). The aim of this study was to initial screen the potential of seven Peronemins compounds in Sungkai leaves extract as anticancer candidates. Initial screening was carried out by predicting in-silico anticancer activity of the seven compounds. Dihydrofolate reductase inhibitor (DHFR inhibitor) is one of the anticancer activity screening approaches. DHFR Inhibitor activity from perenomins derivatives with pIC50 values ​​of 0.785 (A2), respectively; 0.785 (A3); 0.799 (B2); 0.799 (B3); 0.799 (C1 and D1). In addition, from compounds 1,2,3,4,5 peronemin derivatives have potential anticancer activity through interaction with the target protein Voltage-gated potassium channel subunit while compounds 6, 7 also have biological activity potential anticancer on target protein Dihydrofolate reductase. http://online-journal.unja.ac.id/chp/article/view/23726anticancerperoneminsPeronema canescens Jack
spellingShingle Muhammad Fikriansyah
Nelson
Madyawati Latief
Indra Lasmana Tarigan
Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
Chempublish Journal
anticancer
peronemins
Peronema canescens Jack
title Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
title_full Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
title_fullStr Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
title_full_unstemmed Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
title_short Anticancer Activities of Seven Peronemins (A2, A3, B1, B2, B3, C1, and D1) from Peronema canescens Jack: A Prediction Studies
title_sort anticancer activities of seven peronemins a2 a3 b1 b2 b3 c1 and d1 from peronema canescens jack a prediction studies
topic anticancer
peronemins
Peronema canescens Jack
url http://online-journal.unja.ac.id/chp/article/view/23726
work_keys_str_mv AT muhammadfikriansyah anticanceractivitiesofsevenperoneminsa2a3b1b2b3c1andd1fromperonemacanescensjackapredictionstudies
AT nelson anticanceractivitiesofsevenperoneminsa2a3b1b2b3c1andd1fromperonemacanescensjackapredictionstudies
AT madyawatilatief anticanceractivitiesofsevenperoneminsa2a3b1b2b3c1andd1fromperonemacanescensjackapredictionstudies
AT indralasmanatarigan anticanceractivitiesofsevenperoneminsa2a3b1b2b3c1andd1fromperonemacanescensjackapredictionstudies